Vanguard Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$47.6M Sell
2,924,264
-21,909
-0.7% -$378K ﹤0.01% 1913
2026
Q2
$52.9M Buy
2,946,173
+55,349
+2% +$774K ﹤0.01% 1915
2026
Q1
$27.2M Buy
+2,890,824
New +$31.7M ﹤0.01% 2178

Other funds holding IART

Vanguard Capital Management's IART Position: Q3 2026 in Review

Vanguard Capital Management reduced its Integra LifeSciences (IART) stake by 0.74% in Q3 2026, selling an estimated $378K and leaving 2,924,264 shares worth $47.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Vanguard Capital Management first reported a position in IART in Q1 2026 and has held it in 3 quarters since. The position peaked at $52.9M in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Vanguard Capital Management held 2,924,264 shares of Integra LifeSciences worth $47.6M as of Q3 2026.
  • Vanguard Capital Management sold 21,909 Integra LifeSciences shares in Q3 2026, an estimated $378K.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1913 holding.
  • Vanguard Capital Management first reported a position in Integra LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Integra LifeSciences position peaked at $52.9M in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.